-Economic and Political Weekly The Saradha group's collapse has possibly bankrupted lakhs of small investors robbing them of their life svaings, and has rendered thousands of its agents jobless. The scam highlights the failure of the government and its regulatory agencies to reign in the mushrooming chit fund companies in West Bengal. It also brings under the scanner the Trinamool Congress' proximity with the tainted group. In the wake of the...

-The Business Standard A trail of unfulfilled promises follow her in rural and urban Bengal The furious letter-writing since 2010 about the chit fund industry in West Bengal suggests that everyone knew the industry was going to implode. Bengal has one of the highest rates in small savings, Trinamool Congress (TMC) leader Somen Mitra wrote to the prime minister in 2011. The state buys the highest number of new life insurance policies, and...

-The Hindu Shramik Mukti Sanghatana appeals to Jayanthi Natarajan not to give final nod After rejecting a proposal last year, the Forest Advisory Committee (FAC) of the Union Ministry of Environment and Forests (MoEF) has recommended clearance of Land for the controversial Kalu dam in Thane district, drawing sharp criticism from activists and tribals affected by the project. A letter on Thursday to Environment Minister Jayanthi Natarajan, conveyed their "utter shock and dismay"...

-The Hindustan Times As the country enters the election year, the UPA government has its task cut out in the form of legislative commitments which are looking increasingly difficult to fulfil. As many as 115 bills (excluding the finance bill) are pending before Parliament. Among these are the Land acquisition and food security bills that for obvious reasons are high on the Congress-led coalition's social agenda in a poll year. Ninety-three of...

-The Hindu Business Line From maker of versions of drugs, India's pharmaceutical industry has turned a top innovator Twenty years ago, Ranbaxy was a home-spun drug-maker. The Indian Patents Act allowed companies to make chemically-similar versions of innovative drugs. Visionaries in the pharmaceutical sector, like Parvinder Singh (Ranbaxy's key architect and member of its promoter family) and Anji Reddy (founder of Dr Reddy's Laboratories), were alive. And the pharmaceutical industry did not have...